Phase I/II trial of neoadjuvant sunitinib administered with weekly paclitaxel/carboplatin in patients with locally advanced triple-negative breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-015-3482-4
Published Online: 2015-07-09
Published Print: 2015-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Yardley, Denise A.
Shipley, Dianna L.
Peacock, Nancy W.
Shastry, Mythili
Midha, Rajiv
Priego, Victor M.
Hainsworth, John D.
Funding for this research was provided by:
Pfizer
Text and Data Mining valid from 2015-07-09